(Q53113694)
Statements
Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab. (English)
Kristin Skougaard
Dorte Nielsen
Benny Vittrup Jensen
Helle Westergren Hendel
9 April 2013
54
7
1026-1031